DSIP is a small peptide (nine amino acids) first isolated from rabbit brain tissue in the 1970s. It’s named after an early finding that it seemed to increase deep, “delta wave” sleep in animal recordings.
That naming effect is the whole basis of its modern marketing. But later researchers have struggled to reproduce it consistently, and DSIP’s mechanism — and even its core sleep effect — remains unsettled.
No modern human clinical trial has tested DSIP for sleep quality, stress-hormone regulation, or athletic recovery — the uses it’s currently sold for. What exists is decades-old animal data and a name that has outlived the evidence behind it. That’s an unusual gap worth stating plainly: a compound this often recommended for “recovery stacks” has no modern human recovery data at all.